|
2024
|
Invention
|
Methods and compositions for generating modified cells. The present disclosure relates, in part, ... |
|
|
Invention
|
Chimeric antigen receptors comprising toll-like receptor 2 (tlr2) and cd3 zeta signaling domains ... |
|
2023
|
Invention
|
Methods and compositions for generating modified pluripotent cells and derivates thereof. The pre... |
|
|
Invention
|
Engineered cells for therapy. Strategies, systems, compositions, and methods for genetically modi... |
|
|
Invention
|
Chimeric receptors and uses thereof. Provided herein at chimeric receptors comprising an IgG Fc r... |
|
|
Invention
|
Methods and compositions for generating chimeric antigen receptor-monocytes/macrophages. The pres... |
|
|
Invention
|
Chimeric antigen receptors for natural killer cells and uses thereof in immunotherapy.
Provided ... |
|
|
Invention
|
Chimeric antigen receptors for natural killer cells and uses thereof in immunotherapy. CISHCISH-/... |
|
2022
|
Invention
|
Engineered cells for therapy.
Strategies, systems, compositions, and methods for genetically mod... |
|
2021
|
Invention
|
Methods of inducing antibody-dependent cellular cytotoxicity (adcc) using modified natural killer... |
|
2020
|
P/S
|
Research and development regarding cell-based immunotherapies and regenerative medicine; immunoth... |
